Geron Stock Statistic Functions Beta
| GERN Stock | USD 1.60 -0.06 -3.61% |
| Symbol |
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Geron correlated with the market. If Beta is less than 0 Geron generally moves in the opposite direction as compared to the market. If Geron Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Geron is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Geron is generally in the same direction as the market. If Beta > 1 Geron moves generally in the same direction as, but more than the movement of the benchmark.
Geron Technical Analysis Modules
Most technical analysis of Geron help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Geron from various momentum indicators to cycle indicators. When you analyze Geron charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
The stock is currently in a very aggressive trading activities.Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. The company was incorporated in 1990 and is headquartered in Foster City, California. Geron Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 69 people. As a mid-cap equity, Geron is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/B of 4.71, profit margin of -45.41%. Geron has a market cap of 1.02 B, ROE of -32.99%.
Methodology
Unless otherwise specified, financial data for Geron is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Geron (USA Stocks:GERN) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Geron may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardBecome your own money manager
Tracking Geron inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Corona Opportunity Invested few shares | |
 | Warren Buffett Holdings Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Driverless Cars Invested few shares | |
 | Social Domain Invested few shares | |
 | Advertising Invested few shares | |
 | Video Games Invested few shares | |
 | Macroaxis Picks Invested few shares | |
 | Hedge Favorites Invested over 200 shares | |
 | Artificial Intelligence Invested few shares | |
 | Blockchain Invested few shares | |
More Resources for Geron Stock Analysis
Reviewing Geron commonly begins with financial statements and performance trends. Financial ratios provide context for profitability, efficiency, and growth trends. Selected reports below provide context for Geron Stock:Geron has a market cap of 1.02 B, operating margin of -17.72%, ROE of -32.99%. See Risk vs Return Analysis for portfolio-level analysis. This suggests a position in Geron within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. Our How to Buy Geron Stock guide explains the steps to invest in Geron stock.Analysis related to Geron should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Earnings Share -0.13 | Revenue Per Share | Quarterly Revenue Growth 0.01 | Return On Assets | Return On Equity |
Investors evaluate Geron using market value and book value, each describing different facets of the business. Geron's market capitalization is 1.02 B. With a P/B ratio of 4.71, the market values Geron well above its book equity. Enterprise value stands at 827.38 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
The concept of value for Geron differs from its quoted price, since each reflects a different lens. For Geron, key inputs include a P/B ratio of 4.71, a profit margin of -45.41%, ROE of -32.99%, and revenue of 183.88 M. Trading price represents the transaction level agreed by market participants.